SLAS2026

Meet us at Booth 1620: We're looking forward to meeting you in front of our biosensors and Beacon^® solutions that will be on display at our booth. Take the chance to discuss with our experts how our solutions can help you in current and future projects.

Exhibitor Tutorial: Attend our tutorial session hosted by Bruker's expert team to discover the latest biosensor solutions.

NEW PRODUCT ALERT – iNTA: Discover Bruker’s newest label-free technology for characterizing bioparticles such as adenoviruses (AdV) and extracellular vesicles (EV) in the biopharmaceutical and scientific industries.

Tackling new challenges in automated biophysical characterization: From high-throughput hit screening, to bioparticle characterization, to kinetics directly on cells

Location: Room 107A, Meeting Level 1

Lab automation technologies are transforming biologics development by streamlining the selection and optimization of candidates. However, the complexity of biologics—often involving intricate structures and binding interactions—presents challenges in optimizing pharmacokinetics, efficacy, and safety.

In this tutorial, we will not only highlight three advanced automated biophysical tools, but also showcase the all-new iNTA technology for the first time.

You will learn more about:

• high-throughput, multiplexing Surface Plasmon Resonance (SPR) for rapid candidate identification and detailed lead development
• switchSENSE^® for analyzing avidity effects, multispecific binders, and protein conformational changes
• single-cell Interaction Cytometry for real-time kinetic measurements directly on cells to assess native binding properties
• Interferometric Nanoparticle Tracking Analysis (iNTA) for precise sizing and label-free subpopulation differentiation of nanoparticles in native solutions.

These tools offer comprehensive profiling to accelerate biologics development by identifying lead candidates with optimal biophysical characteristics and are also applicable to other therapeutic modalities like small molecules.

As you are certainly aware, special compliance regulations apply to public officials* and healthcare professionals** with regard to the event we are planning. If you accept our invitation, we will therefore assume that you will observe the compliance regulations that apply to you and that you have the necessary employer approval.

*Government Official means according the Bruker policies any of the following: any officer, employee or representative of a government (national, regional or local) entity, or any public agency, public authority, department or instrumentality thereof, regardless of their rank or title (e.g. a regulatory official or government inspector); any person working for or advising a government-owned or government-controlled enterprise (e.g. a professor at a government-owned university, or a purchaser at a government-owned hospital); any person working for or advising a national or international non-governmental organization (e.g. an employee of the Red Cross or The World Bank); any person performing a public function or providing a public service, even if that person works for a non-governmental institution (e.g. private security personnel working in public functions); any person hired to review or accept bids for a government agency; any person with the responsibility to allocate or expend government funds; any person in a public law function, civil servant, judge or military personnel; any person acting for a political party, including party officials, candidates or individuals holding a position in a political party office; members of royal families; or immediate family members of any of the persons listed above. An immediate family member is a grandparent, parent, spouse, significant other, child, or sibling.

**A Healthcare Professional (HCP) is in accordance with the Bruker policies any physician, dentist, nurse, pharmacist or other individual who may prescribe, administer, purchase, dispense, recommend, or supply medical products or treatments or pharmaceutical products. In many cases, Bruker interacts with HCPs who work for state-owned hospitals (e.g. as medical scientists). These individuals will be classified as both HCPs and Government Officials.